You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

IMAT

Cancer Type: Gastrointestinal, Gastrointestinal Stromal Tumours, Sarcoma, GIST      Intent: Palliative
Regimen Category: Evidence-Informed
Funding:
Exceptional Access Program
    iMAtinib - Metastatic Gastrointestinal Stromal Tumours, with specific criteria

You might also be interested in